○Hirona Ichikawa¹, Takao Hijikata¹ (1. Pharm. Musashino Univ.)

○Manami Seki¹, Hirona Ichikawa¹, Takao Hijikata¹ (1. Pharm. Musashino Univ.)

○Kazushi Kuriyama¹, Tadashi Watanabe¹, Shinji Ohno¹ (1. Grad. Sch. Med., Univ. of the Ryukyus)

○Mariko Yamamoto^1,2, Yoshinori Tsukumo¹, Takayoshi Suzuki¹, Kohji Noguchi², Takao Inoue¹ (1. Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences., 2. Faculty of Pharmaceutical Sciences, Tokyo University of Science)

○Miyu Tannaka¹, Keita Takahashi¹, Naoki Inoue¹, Tetsuo Koshizuka¹ (1. Gifu Pharm. Univ.)

○Renxing Yi¹, Rina Hashimoto¹, Ayaka Sakamoto¹, Kazutoshi Takahashi¹, Kazuo Takayama^1,2 (1. CiRA, Kyoto Univ., 2. AMED-CREST)

○DAICHI UTSUMI¹, Masamitsu Asaka¹, Haruhiko Kamada^2,3,4, Satoshi Nagata³, Yutaka Nakachi⁵, Tomokazu Yamaguchi⁶, Yoshihiro Kawaoka^7,8,9, Keiji Kuba⁶, Yasuhiro Yasutomi¹ (1. Tsukuba Primate Res. Ctr., NIBIOHN, 2. Lab. of Biopharmaceutical Res., NIBIOHN, 3. Lab. of Antibody Design., NIBIOHN, 4. Global Ctr for Med. Eng. and Informatics, Osaka Univ., 5. Dept. of Mol. Brain Sci. Grad. Sch. of Med. Sci., Kumamoto Univ., 6. Dept. of Biochem. and Metabolic Sci., Grad. Sch. of Med., Akita Univ., 7. Influenza Res. Inst., Dept. of Pathobiological Sci., Sch. of Veterinary Med., Univ. of Wisconsin, 8. Divi. of Virology, Dept. of Microbiol. and Immunol. Inst. of Med. Sci., Univ. of Tokyo, 9. Natl. Ctr. for Global Health and Med.)

○Ryosuke Miki¹, Dai Hatakeyama¹, Takeshi Masuda², Yukiko Muramoto³, Takeshi Noda³, Sumio Otuki², Takashi Kuzuhara¹ (1. Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Tokusima Bunri University, Japan, 2. Department of Pharmaceutical Microbiology, Graduate School of Pharmaceutical Sciences, Kumamoto University, JApan, 3. Institute for Frontier Life and Nedical Sciences, Kyoto University, Japan)

○Tetsuya Inoue¹, Yuichiro Yamamoto¹, Mana Murae^1,2, Masayosi Fukasawa^1,2, Mika Kaneko³, Yukinari Kato³, Kohji Noguchi^1,2 (1. Facult. Pharm. Sci. Tokyo Univ. Sci., 2. Natl. Inst. Infect. Dis., 3. Tohoku Univ. Grad. Sch. Med.)

○Yukari Ishida¹, Ryuki Sakai¹, Miki Umeda^1,2, Masaya Takemoto¹, Tohru Daikoku¹ (1. Pharm. Sci., Hokuriku Univ., 2. Grad. Sch. Med., Nagoya Univ.)

○Shinako Suzuki¹, Shiho Minami¹, Miki Umeda^1,2, Masaya Takemoto¹, Tohru Daikoku¹ (1. Pharm. Sci., Hokuriku Univ., 2. Grad. Sch. Med., Nagoya Univ.)

○Tohru Daikoku¹, Arisa Minami¹, Miki Umeda^1,2, Masaya Takemoto¹, Tokutaro Ogata¹ (1. Pharm. Sci., Hokuriku Univ., 2. Grad. Sch. Med., Nagoya Univ.)